Terms: = Liver cancer AND BRD3, KIAA0043, 8019, ENSG00000169925, Q15059, ORFX, RING3L AND Treatment
1 results:
1. [Preliminary efficacy and safety analysis of carrelizumab combined with apatinib in patients with middle-advanced liver cancer progressed after drug-eluting beads-transcatheter arterial chemoembolization].
Liu J; Cao G; Zhang GS; Xu WJ; Liu SY; Shi DQ
Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(29):2304-2309. PubMed ID: 34333946
[No Abstract] [Full Text] [Related]
